Research graph
References from Sex Differences in Coronary Atheroma Regression After Intensive Lipid-Lowering Therapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Heart disease and stroke statistics—2021 update: a report from the American Heart Association
10.1161/cir.0000000000000950 · 2021 · External reference
Intensive versus moderate lipid lowering with statin after acute coronary syndromes
10.1056/nejmoa040583 · 2004 · External reference
Atherosclerotic coronary plaque regression and risk of adverse cardiovascular events: a systematic review and updated meta-regression analysis
10.1001/jamacardio.2023.2731 · 2023 · External reference
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial (REVERSAL)
10.1001/jama.291.9.1071 · 2004 · External reference
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial
10.1001/jama.295.13.jpc60002 · 2006 · External reference
Effect of two intensive statin regimens on progression of coronary disease: the SATURN trial
10.1056/nejmoa1110874 · 2011 · External reference
Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial
10.1001/jama.2016.16951 · 2016 · External reference
Effect of alirocumab on coronary atherosclerosis in patients with acute myocardial infarction (PACMAN-AMI)
10.1001/jama.2022.5218 · 2022 · External reference
2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
10.1093/eurheartj/ehz455 · 2020 · External reference
2018 AHA/ACC guideline on the management of blood cholesterol
10.1016/j.jacc.2018.11.003 · 2019 · External reference
Sex differences in 10-Year outcomes after percutaneous coronary intervention with drug-eluting stents: insights from the DECADE cooperation
10.1161/circulationaha.122.062049 · 2023 · External reference
Assessment of sex disparities in nonacceptance of statin therapy and low-density lipoprotein cholesterol levels among patients at high cardiovascular risk
10.1001/jamanetworkopen.2023.1047 · 2023 · External reference
Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the REGARDS study
10.1161/jaha.116.004264 · 2017 · External reference
Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN
10.1016/j.jcmg.2014.04.019 · 2014 · External reference
Coronary atheroma progression rates in men and women following high-intensity statin therapy: pooled analysis from REVERSAL, ASTEROID and SATURN
10.1016/j.atherosclerosis.2016.09.059 · 2016 · External reference
Coronary atherosclerotic plaque regression: JACC state-of-the-art review
10.1016/j.jacc.2021.10.035 · 2022 · External reference
Effect of icosapent ethyl on progression of coronary atherosclerosis (EVAPORATE trial)
10.1093/eurheartj/ehaa652 · 2020 · External reference
Lipid disorders in women: differences and implications for therapy
2022 · External reference
Sex differences in plaque characteristics by intravascular imaging in patients with coronary artery disease
10.4244/eij-d-16-00361 · 2017 · External reference
The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis
10.1038/s41598-021-87528-w · 2021 · External reference
Prognostic value of plaque volume in patients with first diagnosis of coronary artery disease: a substudy of the PROMISE randomized clinical trial
10.1001/jamacardio.2025.5520 · 2026 · External reference
Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study
10.1016/j.jacc.2018.10.066 · 2019 · External reference
Dysfunctional HDL and atherosclerotic cardiovascular disease
10.1038/nrcardio.2015.124 · 2016 · External reference
Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia
10.1016/j.jacl.2022.11.009 · 2023 · External reference
Effects of torcetrapib in patients at high risk for coronary events (ILLUMINATE)
10.1056/nejmoa0706628 · 2007 · External reference
Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression
10.1097/gme.0b013e31803c764d · 2007 · External reference
Sex differences in diagnostic modalities of atherosclerosis in the macrocirculation
10.1016/j.atherosclerosis.2023.117275 · 2023 · External reference
The importance of the endothelium in atherothrombosis and coronary artery disease
10.1038/nrcardio.2012.64 · 2012 · External reference
Healthy strut coverage after coronary stent implantation: an Ex vivo human autopsy study
10.1161/circinterventions.119.008869 · 2020 · External reference
Sex-related differences in thrombus burden in STEMI patients undergoing primary percutaneous coronary intervention
10.1016/j.jcin.2022.08.013 · 2022 · External reference
Anti-inflammatory therapy with canakinumab for atherosclerotic disease (CANTOS trial)
10.1056/nejmoa1707914 · 2017 · External reference
Inflammation and its resolution as determinants of acute coronary syndromes
10.1161/circresaha.114.302699 · 2014 · External reference
NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography
10.1016/j.jcmg.2011.03.013 · 2011 · External reference
Evolocumab and clinical outcomes in patients with cardiovascular disease (FOURIER)
10.1056/nejmoa1615664 · 2017 · External reference
Alirocumab and cardiovascular outcomes after acute coronary syndrome (ODYSSEY outcomes)
10.1056/nejmoa1801174 · 2018 · External reference
Emerging non-statin treatment options for lowering low-density lipoprotein cholesterol
10.3389/fcvm.2021.789931 · 2021 · External reference
Update on the use of PCSK9 inhibitors in adults: recommendations from an expert panel of the National Lipid Association
10.1016/j.jacl.2017.05.001 · 2017 · External reference
Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients
10.1016/j.jacc.2006.10.079 · 2007 · External reference
Effect of torcetrapib on progression of coronary atherosclerosis
10.1056/nejmoa070635 · 2007 · External reference
Changes in plaque lipid content after intensive versus standard statin therapy: the YELLOW trial
10.1016/j.jacc.2013.03.058 · 2013 · External reference
Sex/gender differences in cardiovascular disease prevention
10.1161/circulationaha.110.968792 · 2011 · External reference
Sex and gender differences in health: science & society series on sex and science
10.1038/embor.2012.87 · 2012 · External reference
Clinical relevance and application of optical coherence tomography
2015 · External reference
A prospective natural-history study of coronary atherosclerosis
10.1056/nejmoa1002358 · 2011 · External reference
Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial
10.1001/jama.2016.16951 · ExternalCitation · doi-reference
Effect of alirocumab on coronary atherosclerosis in patients with acute myocardial infarction (PACMAN-AMI)
10.1001/jama.2022.5218 · ExternalCitation · doi-reference
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial (REVERSAL)
10.1001/jama.291.9.1071 · ExternalCitation · doi-reference
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial
10.1001/jama.295.13.jpc60002 · ExternalCitation · doi-reference
Atherosclerotic coronary plaque regression and risk of adverse cardiovascular events: a systematic review and updated meta-regression analysis
10.1001/jamacardio.2023.2731 · ExternalCitation · doi-reference
Prognostic value of plaque volume in patients with first diagnosis of coronary artery disease: a substudy of the PROMISE randomized clinical trial
10.1001/jamacardio.2025.5520 · ExternalCitation · doi-reference
Assessment of sex disparities in nonacceptance of statin therapy and low-density lipoprotein cholesterol levels among patients at high cardiovascular risk
10.1001/jamanetworkopen.2023.1047 · ExternalCitation · doi-reference
Coronary atheroma progression rates in men and women following high-intensity statin therapy: pooled analysis from REVERSAL, ASTEROID and SATURN
10.1016/j.atherosclerosis.2016.09.059 · ExternalCitation · doi-reference
Sex differences in diagnostic modalities of atherosclerosis in the macrocirculation
10.1016/j.atherosclerosis.2023.117275 · ExternalCitation · doi-reference
Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients
10.1016/j.jacc.2006.10.079 · ExternalCitation · doi-reference
Changes in plaque lipid content after intensive versus standard statin therapy: the YELLOW trial
10.1016/j.jacc.2013.03.058 · ExternalCitation · doi-reference
Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study
10.1016/j.jacc.2018.10.066 · ExternalCitation · doi-reference
2018 AHA/ACC guideline on the management of blood cholesterol
10.1016/j.jacc.2018.11.003 · ExternalCitation · doi-reference
Coronary atherosclerotic plaque regression: JACC state-of-the-art review
10.1016/j.jacc.2021.10.035 · ExternalCitation · doi-reference
Update on the use of PCSK9 inhibitors in adults: recommendations from an expert panel of the National Lipid Association
10.1016/j.jacl.2017.05.001 · ExternalCitation · doi-reference
Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia
10.1016/j.jacl.2022.11.009 · ExternalCitation · doi-reference
Sex-related differences in thrombus burden in STEMI patients undergoing primary percutaneous coronary intervention
10.1016/j.jcin.2022.08.013 · ExternalCitation · doi-reference
NIRS and IVUS for characterization of atherosclerosis in patients undergoing coronary angiography
10.1016/j.jcmg.2011.03.013 · ExternalCitation · doi-reference
Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN
10.1016/j.jcmg.2014.04.019 · ExternalCitation · doi-reference
Sex and gender differences in health: science & society series on sex and science
10.1038/embor.2012.87 · ExternalCitation · doi-reference
The importance of the endothelium in atherothrombosis and coronary artery disease
10.1038/nrcardio.2012.64 · ExternalCitation · doi-reference
Dysfunctional HDL and atherosclerotic cardiovascular disease
10.1038/nrcardio.2015.124 · ExternalCitation · doi-reference
The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis
10.1038/s41598-021-87528-w · ExternalCitation · doi-reference
Intensive versus moderate lipid lowering with statin after acute coronary syndromes
10.1056/nejmoa040583 · ExternalCitation · doi-reference
Effect of torcetrapib on progression of coronary atherosclerosis
10.1056/nejmoa070635 · ExternalCitation · doi-reference
Effects of torcetrapib in patients at high risk for coronary events (ILLUMINATE)
10.1056/nejmoa0706628 · ExternalCitation · doi-reference
A prospective natural-history study of coronary atherosclerosis
10.1056/nejmoa1002358 · ExternalCitation · doi-reference
Effect of two intensive statin regimens on progression of coronary disease: the SATURN trial
10.1056/nejmoa1110874 · ExternalCitation · doi-reference
Evolocumab and clinical outcomes in patients with cardiovascular disease (FOURIER)
10.1056/nejmoa1615664 · ExternalCitation · doi-reference
Anti-inflammatory therapy with canakinumab for atherosclerotic disease (CANTOS trial)
10.1056/nejmoa1707914 · ExternalCitation · doi-reference
Alirocumab and cardiovascular outcomes after acute coronary syndrome (ODYSSEY outcomes)
10.1056/nejmoa1801174 · ExternalCitation · doi-reference
Effect of icosapent ethyl on progression of coronary atherosclerosis (EVAPORATE trial)
10.1093/eurheartj/ehaa652 · ExternalCitation · doi-reference
2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
10.1093/eurheartj/ehz455 · ExternalCitation · doi-reference
Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression
10.1097/gme.0b013e31803c764d · ExternalCitation · doi-reference
Heart disease and stroke statistics—2021 update: a report from the American Heart Association
10.1161/cir.0000000000000950 · ExternalCitation · doi-reference
Healthy strut coverage after coronary stent implantation: an Ex vivo human autopsy study
10.1161/circinterventions.119.008869 · ExternalCitation · doi-reference
Inflammation and its resolution as determinants of acute coronary syndromes
10.1161/circresaha.114.302699 · ExternalCitation · doi-reference
Sex/gender differences in cardiovascular disease prevention
10.1161/circulationaha.110.968792 · ExternalCitation · doi-reference
Sex differences in 10-Year outcomes after percutaneous coronary intervention with drug-eluting stents: insights from the DECADE cooperation
10.1161/circulationaha.122.062049 · ExternalCitation · doi-reference
Race-sex differences in statin use and low-density lipoprotein cholesterol control among people with diabetes mellitus in the REGARDS study
10.1161/jaha.116.004264 · ExternalCitation · doi-reference
Emerging non-statin treatment options for lowering low-density lipoprotein cholesterol
10.3389/fcvm.2021.789931 · ExternalCitation · doi-reference
Sex differences in plaque characteristics by intravascular imaging in patients with coronary artery disease
10.4244/eij-d-16-00361 · ExternalCitation · doi-reference
